$38m Series A for bio-tracker Levels

#shorts

🚑 Levels, a New York-based developer of metabolic biosensors, raised $38m in Series A funding at a $300m valuation. Backers include Andreessen Horowitz and individuals like Andrea Funsten, Ben Gilbert and David Rosenthal